Xtampza Not Infringing 2 OxyContin Patents, Judge Says
An opioid painkiller designed to deter sniffing and injection does not infringe two of Purdue Pharma LP's OxyContin-related patents, a Massachusetts federal judge has ruled in a victory for Collegium Pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article